Supernus Pharmaceuticals relocates to Gaithersburg, adds jobs

Rockville-based Supernus Pharmaceuticals plans to move its headquarters to Gaithersburg in 2019 and potentially double its work force over the next five years.

The operation will include research and development and manufacturing facilities in a 118,000-suare-foot building in Gaithersburg, home to many life science companies. Supernus currently employs 156.

The company develops and commercializes products to treat central nervous system diseases. Supermus currently markets Trokendi XR to prevent migraines and treat epilepsy, and Oxtellar XR for epilepsy. It’s developing psychiatric treatments for impulsive aggression and attention-deficit/hyperactivity disorder.

The move and expansion was announced by Gov. Larry Hogan, who called Supernus one of the fastest growing biotech-pharma companies in the region.

The state Department of Commerce has approved giving Supernus $800,000 in state funds for use on certain company expenses and a $90,000 for worker training. Montgomery County is providing a $500,000 grant and Gaithersburg is offering a $400,000 grant.

Copyright © 2018, The Baltimore Sun, a Baltimore Sun Media Group publication | Place an Ad